Korean J Women Health Nurs.  2015 Jun;21(2):106-114. 10.4069/kjwhn.2015.21.2.106.

A Review of Postpartum Depression: Focused on Psychoneuroimmunological Interaction

• Kim Y
• Ahn S

• KMID: 2307924
• DOI: http://doi.org/10.4069/kjwhn.2015.21.2.106

Abstract

PURPOSE
The purpose of this review was to describe a psychoneuroimmunology (PNI) framework for postpartum depression (PPD) and discuss its implications for nursing research and practice for postpartum women.
METHODS
This study explored the role of hypothalamic-pituitary-adrenal (HPA) axis and inflammation as possible mediators of risk factors for PPD through literature review.
RESULTS
From this PNI view, human bodies are designed to respond with the reciprocal interactions among the neuro-endocrine and immune system when they are faced with physical or psychological stressors. Chronic stress induces alterations in the function of HPA axis, and a chronic low-grade inflammatory response is associated with depression. The dysfunctions of cytokines and HPA axis have been observed during the postpartum period. Stress promotes glucocorticoid receptor resistance, which can promote inflammatory responses. This, in turn, can contribute to the pathophysiology of depression. This can especially affect populations at vulnerable time-points, such as women in the postpartum.
CONCLUSION
From a PNI perspective, well-designed prospective research evaluating the role of stress and inflammation as an etiology of PPD and the effect of stress reduction is warranted to prevent PPD.

Keyword

Postpartum depression; Stress; Inflammation; Cytokines; Glucocorticoid; Psychoneuroimmunology

MeSH Terms

Axis, Cervical Vertebra
Cytokines
Depression
Depression, Postpartum*
Female
Human Body
Humans
Immune System
Inflammation
Nursing Research
Postpartum Period
Psychoneuroimmunology
Receptors, Glucocorticoid
Risk Factors
Cytokines
Receptors, Glucocorticoid

Reference

1. Beck CT. State of the science on postpartum depression: What nurse researchers have contributed-Part 1. MCN Am J Matern Child Nurs. 2008; 33(2):121–126.

2. Barker ED, Jaffee SR, Uher R, Maughan B. The contribution of prenatal and postnatal maternal anxiety and depression to child maladjustment. Depress Anxiety. 2011; 28(8):696–702.

3. Jones NA. Delayed reactive cries demonstrate emotional and physiological dysregulation in newborns of depressed mothers. Biol Psychol. 2012; 89(2):374–381.

4. Murray L, Arteche A, Fearon P, Halligan S, Goodyer I, Cooper P. Maternal postnatal depression and the development of depression in offspring up to 16 years of age. J Am Acad Child Adolesc Psychiatry. 2011; 50(5):460–470.

5. McCoy SJ, Beal JM, Watson GH. Endocrine factors and postpartum depression. A selected review. J Reprod Med. 2003; 48(6):402–408.

6. Bloch M, Rubinow DR, Schmidt PJ, Lotsikas A, Chrousos GP, Cizza G. Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. J Clin Endocrinol Metab. 2005; 90(2):695–699.

7. Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM, et al. Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry. 2010; 67(5):468–474.

8. Glynn LM, Davis EP, Sandman CA. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Neuropeptides. 2013; 47(6):363–370.

9. Kendall-Tackett K. A new paradigm for depression in new mothers: The central role of inflammation and how breast-feeding and anti-inflammatory treatments protect maternal mental health. Int Breastfeed J. 2007; 2:6.

10. Corwin EJ, Pajer K. The psychoneuroimmunology of postpartum depression. J Womens Health (Larchmt). 2008; 17(9):1529–1534.

11. Osborne LM, Monk C. Perinatal depression-the fourth inflammatory morbidity of pregnancy? Theory and literature review. Psychoneuroendocrinology. 2013; 38(10):1929–1952.

12. Song HR, Woo YS, Bahk WM. Depression as an Inflammatory Disease. Korean J Psychopharmacol. 2013; 24(1):5–10.

13. Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35(3):722–729.

14. Bockting CL, Lok A, Visser I, Assies J, Koeter MW, Schene AH, et al. Lower cortisol levels predict recurrence in remitted patients with recurrent depression: A 5.5 year prospective study. Psychiatry Res. 2012; 200(2-3):281–287.

15. Leonard BE. Impact of inflammation on neurotransmitter changes in major depression: An insight into the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 48:261–267.

16. Corwin EJ, Guo Y, Pajer K, Lowe N, McCarthy D, Schmiege S, et al. Immune dysregulation and glucocorticoid resistance in minority and low income pregnant women. Psychoneuroendocrinology. 2013; 38(9):1786–1796.

17. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35(3):664–675.

18. Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013; 11:200.

19. Glynn LM, Sandman CA. Evaluation of the association between placental corticotrophin-releasing hormone and postpartum depressive symptoms. Psychosom Med. 2014; 76(5):355–362.

20. Mastorakos G, Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003; 997:136–149.

21. Jolley SN, Elmore S, Barnard KE, Carr DB. Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression. Biol Res Nurs. 2007; 8(3):210–222.

22. Groer MW, Morgan K. Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology. 2007; 32(2):133–139.

23. Taylor A, Glover V, Marks M, Kammerer M. Diurnal pattern of cortisol output in postnatal depression. Psychoneuroendocrinology. 2009; 34(8):1184–1188.

24. Groer ME, Jevitt C, Ji M. Immune changes and dysphoric moods across the postpartum. Am J Reprod Immunol. 2015; 73(3):193–198.

25. Corwin EJ, Johnston N, Pugh L. Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum. Biol Res Nurs. 2008; 10(2):128–133.

26. Boufidou F, Lambrinoudaki I, Argeitis J, Zervas IM, Pliatsika P, Leonardou AA, et al. CSF and plasma cytokines at delivery and postpartum mood disturbances. J Affect Disord. 2009; 115(1-2):287–292.

27. Kondo N, Suda Y, Nakao A, Oh-Oka K, Suzuki K, Ishimaru K, et al. Maternal psychosocial factors determining the concentrations of transforming growth factor-beta in breast milk. Pediatr Allergy Immunol. 2011; 22(8):853–861.

28. Fransson E, Dubicke A, Bystrom B, Ekman-Ordeberg G, Hjelmstedt A, Lekander M. Negative emotions and cytokines in maternal and cord serum at preterm birth. Am J Reprod Immunol. 2012; 67(6):506–514.

29. Yim IS, Tanner Stapleton LR, Guardino CM, Hahn-Holbrook J, Dunkel Schetter C. Biological and psychosocial predictors of postpartum depression: Systematic review and call for integration. Annu Rev Clin Psychol. 2015; 11:99–137.

30. Logsdon MC, Tomasulo R, Eckert D, Beck C, Dennis CL. Identification of mothers at risk for postpartum depression by hospital-based perinatal nurses. MCN Am J Matern Child Nurs. 2012; 37(4):218–225.